207 related articles for article (PubMed ID: 10385640)
1. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis.
Jones DE; Palmer JM; Yeaman SJ; Kirby JA; Bassendine MF
Hepatology; 1999 Jul; 30(1):65-70. PubMed ID: 10385640
[TBL] [Abstract][Full Text] [Related]
2. A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse.
Robe AJ; Kirby JA; Jones DE; Palmer JM
Hepatology; 2005 May; 41(5):1106-12. PubMed ID: 15830397
[TBL] [Abstract][Full Text] [Related]
3. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex.
Jones DE; Palmer JM; Burt AD; Walker C; Robe AJ; Kirby JA
Hepatology; 2002 Sep; 36(3):679-86. PubMed ID: 12198661
[TBL] [Abstract][Full Text] [Related]
4. Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse.
Palmer JM; Robe AJ; Burt AD; Kirby JA; Jones DE
Hepatology; 2004 Jun; 39(6):1583-92. PubMed ID: 15185299
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis.
Bassendine MF; Jones DE; Yeaman SJ
Semin Liver Dis; 1997 Feb; 17(1):49-60. PubMed ID: 9089910
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
Ikuno N; Scealy M; Davies JM; Whittingham SF; Omagari K; Mackay IR; Rowley MJ
Hepatology; 2001 Sep; 34(3):478-86. PubMed ID: 11526532
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.
Tsuneyama K; Van de Water J; Leung PS; Cha S; Nakanuma Y; Kaplan M; De Lellis R; Coppel R; Ansari A; Gershwin ME
Hepatology; 1995 Apr; 21(4):1031-7. PubMed ID: 7535733
[TBL] [Abstract][Full Text] [Related]
8. PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis.
McHugh A; Robe AJ; Palmer JM; Jones DE
Liver Int; 2006 May; 26(4):406-13. PubMed ID: 16629643
[TBL] [Abstract][Full Text] [Related]
9. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.
Bogdanos DP; Baum H; Gunsar F; Arioli D; Polymeros D; Ma Y; Burroughs AK; Vergani D
Scand J Gastroenterol; 2004 Oct; 39(10):981-7. PubMed ID: 15513338
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis.
Migliaccio C; Nishio A; Van de Water J; Ansari AA; Leung PS; Nakanuma Y; Coppel RL; Gershwin ME
J Immunol; 1998 Nov; 161(10):5157-63. PubMed ID: 9820485
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis.
Palmer JM; Jones DE; Quinn J; McHugh A; Yeaman SJ
Hepatology; 1999 Jul; 30(1):21-6. PubMed ID: 10385634
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy.
Jones DE; Palmer JM; Kirby JA; De Cruz DJ; McCaughan GW; Sedgwick JD; Yeaman SJ; Burt AD; Bassendine MF
Liver; 2000 Oct; 20(5):351-6. PubMed ID: 11092252
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
Chen QY; Rowley MJ; Mackay IR
Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
[TBL] [Abstract][Full Text] [Related]
14. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis.
Malmborg AC; Shultz DB; Luton F; Mostov KE; Richly E; Leung PS; Benson GD; Ansari AA; Coppel RL; Gershwin ME; Van de Water J
J Autoimmun; 1998 Oct; 11(5):573-80. PubMed ID: 9802945
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME
J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455
[TBL] [Abstract][Full Text] [Related]
17. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis.
Kaplan MM
Am J Gastroenterol; 2004 Nov; 99(11):2147-9. PubMed ID: 15554995
[TBL] [Abstract][Full Text] [Related]
18. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterization of the autoantigenic region and effects of enzymatic delipoylation and relipoylation.
Koike K; Ishibashi H; Koike M
Hepatology; 1998 Jun; 27(6):1467-74. PubMed ID: 9620315
[TBL] [Abstract][Full Text] [Related]
20. Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis-associated autoantigen, pyruvate dehydrogenase complex.
Jones DE; Palmer JM; Bennett K; Robe AJ; Yeaman SJ; Robertson H; Bassendine MF; Burt AD; Kirby JA
Lab Invest; 2002 Feb; 82(2):211-9. PubMed ID: 11850534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
